In summary, the heightened expression of STAMBPL1 not only impacts the proliferation and metastasis of HCC cells but also serves as an ominous predictor of poor prognosis in HCC patients, suggesting that exploring STAMBPL1-based research could offer promising avenues for enhancing the prognosis of HCC patients. The gene discussed is STAMBPL1; the disease is hepatocellular carcinoma.